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Summary
Hematopoiesis occurs in the liver and the bone mar-
row (BM) during murine development. Newborn mice
with a ubiquitous deletion of IB develop a severe
hematological disorder characterized by an increase
of granulocyte/erythroid/monocyte/macrophage col-
ony-forming units (CFU-GEMM) and hypergranulo-
poiesis. Here, we report that this particular myelopro-
liferative disturbance is mediated by continuously
deregulated perinatal expression of Jagged1 in IB-
deficient hepatocytes. The result is a permanent acti-
vation of Notch1 in neutrophils. In contrast, in mice
with a conditional deletion of IB only in the myeloid
lineage (ikbaflox/flox × LysM-Cre) and in fetal liver cell
chimeras (ikbaFL/FL), a cell-autonomous induction
of the myeloproliferative disease was not observed.
Coculture of IB-deficient hepatocytes with wild-
type (wt) BM cells induced a Jagged1-dependent in-
crease in CFUs. In summary, we show that cell-fate
decisions leading to a premalignant hematopoietic*Correspondence: rudolf.rupec@med.uni-muenchen.de (R.R.); klaus.
pfeffer@uni-duesseldorf.de (K.P.)
6 These authors contributed equally to this work.disorder can be initiated by nonhematopoietic cells
with inactive IB.
Introduction
Myelopoiesis is a complex process where granulocytes
as well as macrophages, erythrocytes, and megakaryo-
cytes differentiate from a common myeloid progenitor
(Akashi et al., 2000). Up to now, soluble factors such as
interleukin-3 (IL-3), granulocyte/macrophage colony-
stimulating factor (GM-CSF), and granulocyte colony-
stimulating factor (G-CSF) are known to control sur-
vival, proliferation, and differentiation. These cytokines
regulate transcription factors such as NF-κB, JunB,
PU.1, C/EBP-α, and C/EBP- that are involved in lin-
eage maturation of neutrophils from early precursor
stages up to the mature cell (Friedman, 2002; Tenen et
al., 1997). A failure in the control of cell proliferation and
differentiation during myelopoiesis may result in leuke-
mogenesis (Passegué et al., 2001).
Transcription factors of the NF-κB family are inti-
mately involved in cellular processes of proliferation
and differentiation of hematopoietic lineages. NF-κB is
a complex formed by homo- and heterodimerization of
the NF-κB/Rel family members p50 (NF-κB1), p52 (NF-
κB2), RelA (p65), RelB, and c-Rel. IκBs (inhibitors of NF-
κB) retain the transcription factor NF-κB in the cyto-
plasm, masking its nuclear localization signal, thereby
inhibiting its translocation to the nucleus. The IκB fam-
ily consists of IκBα, IκBβ, IκBγ, IκB, Bcl-3, p100, and
p105. Activation of cells by various stimuli results in
serine phosphorylation of IκBα by the IκB kinase signa-
losom, followed by degradation of IκBα and subse-
quent translocation of NF-κB to the nucleus (Ghosh
and Karin, 2002). Results from transgenic mice and tis-
sue cultures demonstrated the pivotal role of NF-κB for
immunological (Li and Verma, 2002), developmental
(Siebenlist, 1997), and oncogenic (Karin et al., 2002)
processes. It has been described that the ubiquitous
loss of IκBα leads to perinatal mortality (Beg et al.,
1995; Klement et al., 1996).
The recent demonstration that NF-κB is essential for
the survival of BM stem cells points to its important
regulatory role in hematopoiesis (Pyatt et al., 1999). The
functional role of NF-κB in myelopoiesis is still not clear.
Mice deficient for IκBα (Beg et al., 1995; Klement et al.,
1996) as well as recipients of hematopoietic stem cells
deficient for RelA/p50 and RelA/c-Rel develop a hyper-
granulopoiesis (Grossmann et al., 1999; Horwitz et al.,
1997; Weih et al., 1995).
Signaling through Notch family cell surface receptors
has been shown to be involved in cell fate decisions of
stem cells during hematopoietic-mesenchymal differ-
entiation. The role of Notch signaling in myelopoiesis is
still under discussion, as results gained by using dif-
ferent experimental conditions are contradictory. Al-
though some reports demonstrated that the constitu-
tively expressed active intracellular domain of Notch1
(Notch1IC) inhibits lineage differentiation (Bigas et al.,
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480Figure 1. Generation of Conditional Ikba Knockout Mice
(A) Wild-type (wt) ikba locus and targeting construct. Exons (EI–EVI) are depicted as orange boxes. The positions of the thymidine kinase
selection cassette (green box), loxP sites (red arrows), and neomycine selection cassette (blue box) are indicated. The filled circles symbolize
the proximal promoter region. Homologous recombination and removal of the loxP-flanked neomycine cassette give rise to the properly
targeted allele referred to as ikba flox. The deleted allele is referred to as ikba. The probe used for Southern blot, the positions of the PCR
primers (black arrows), and the following restriction sites are indicated: BamHI, B; ClaI, C; EcoRI, E; KpnI, K; NotI, N; SalI, S; and Xba I, Xb.
(B) Identification of the ikba neoflox, ikba flox, and ikba allele by Southern blot analysis. Genotypes and positions of the expected 16 kb wt
(+), 7.60 kb neoflox, 5.60 kb flox, and 2.75 kb  bands are indicated.
(C) For germline deletion of the ikba gene, we crossed ikbaf/f mice with Deleter-Cre mice. Ikba alleles () were identified by PCR on DNA
extracted from various organs of ikba/ mice. The ikba flox allele (flox) was identified only on DNA extracted from the tail of ikbaf/ mice
serving as control.1998; Li et al., 1998; Milner et al., 1996; Varnum-Finney e
met al., 1998), other reports demonstrated that Notch1
promotes myeloid (Schroeder and Just, 2000) or lym- r
phoid (Stier et al., 2002) differentiation. The Notch li-
gand Jagged1 has been discussed as a potential w
egrowth-promoting factor for hematopoietic stem cells
via activation of Notch1 (Jones et al., 1998; Karanu et (
tal., 2000; Varnum-Finney et al., 1998). Again, in con-
trast, other reports argue that expression of constitu- r
vtively active forms of Notch as well as activation of
Notch1 by Jagged1 inhibit the differentiation of myeloid m
pprogenitor cell lines (Carlesso et al., 1999; Li et al.,
1998; Milner et al., 1996; Walker et al., 1999). Due to nmbryonic lethality of Notch1- and Jagged1-deficient
ice, alterations of myelopoiesis are difficult to be ad-
essed (Swiatek et al., 1994; Xue et al., 1999).
Here, we investigated the function of IκBα and its role
ithin the Jagged-Notch signaling pathway during my-
lopoiesis. Therefore, a mouse line with a conditional
floxed) allele of ikba was established. Ubiquitous dele-
ion of IκBα after crossbreeding with Deleter-Cre mice
esults in hypergranulopoiesis comparable to the con-
entional deletion of the allele (Beg et al., 1995; Kle-
ent et al., 1996). A detailed analysis revealed a myelo-
roliferative disease and upregulation of Notch1 in
eutrophils and Jagged1 in nonhematopoietic cells.
Dysregulated Myelopoiesis in IκBα-Deficient Mice
481Figure 2. Dysregulated Myelopoiesis in Ikba/ Mice
(A) Flow cytometric analysis of cells from the liver from embryonic day 12 (E12) up to day 5 postpartum reveals an increase in Gr-1hi/Mac-1hi
granulocytes in ikba/ mice from day 3 on compared to wt mice.
(B) Electrophoretic mobility shift assay (EMSA) of sorted primary Gr-1hi/Mac-1hi granulocyte extracts obtained from 5-day-old ikba/ and
ikba+/+ mice. A radiolabeled NF-κB consensus oligonucleotide was used as a binding probe. The arrows indicate the mobility of the NF-κB
binding activity.
(C) Hematopoiesis (arrows) is significantly reduced in 5-day-old ikba/ mice (right) compared to 3-day-old ikba/ mice (left).
(D) Livers from 3- (left) and 5-day-old (right) ikba/ mice (bottom) show a predominance of cells staining positively for the myeloid marker
chloracetate esterase compared to ikba+/+ mice (top).Myeloproliferation could be inhibited by blocking the
Notch1 ligand Jagged1. Interestingly, deletion of IκBα
in neutrophils and macrophages or hematopoietic stem
cells did not result in dysregulation of myelopoiesis, de-spite constitutive NF-κB activation in these cells. This
establishes the relevance of nonhematopoietic expres-
sion of Jagged1 for the control and regulation of myelo-
poiesis.
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482Figure 3. Newborn Ikba/ Mice Develop a Myelodysplastic Syndrome with Progression to Secondary Acute Myeloid Leukemia
(A) Flow cytometric analysis of cells from bone marrow (BM) showing an increase of Gr-1hi/Mac-1hi granulocytes and Ter-119 erythropoietic
cells in 5-day-old ikba/ mice.
(B) Colony-forming assays were performed with BM cells isolated from ikba/ and ikba+/+ mice. Results are the mean ± SD of three analyzed
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483condensed chromatin and an asynchrony of the nu-ikba mice (Figure 2A). This was paralleled by an in-
mice per time point and genotype.
(C) Flow cytometric analysis of propidium iodide-labeled Gr-1hi BM cells from ikba+/+ (top) and ikba/ (bottom) mice. Cell cycle phase
distribution was assessed by using ModFit cell cycle analysis software.
(D) BM of 5-day-old ikba+/+ and ikba/ mice. The marrow cavity of ikba/ mice shows increased numbers of mostly mature granulocytes with
dysplastic features like micromegakaryocytes (arrow) and pseudo-Pelger-Huët formation (star). The remaining erythropoiesis has condensed
chromatin and an asynchrony of the nucleocytoplasmic ratio (arrowheads) (original magnification 400×).
(E) Wright-Giemsa-stained blood smears from 5-day-old ikba/ mice showing blast cells (arrowheads) in the peripheral blood.Results
Generation of Gene-Targeted Mice
with a Conditional ikba Allele
Complete inactivation of ikba results in hypergranulo-
poiesis and perinatal death (Beg et al., 1995; Klement et
al., 1996). The specific role of IκBα causing hypergran-
ulopoiesis has not yet been identified. In order to ana-
lyze the mechanism that is responsible for hypergran-
ulopoiesis, we utilized the Cre-loxP recombination
system to generate a mouse line that allows tissue-
selective deletion of ikba. Specific sequence motifs,
loxP sites, were introduced into the ikba locus of mouse
embryonic stem (ES) cells by homologous recombina-
tion (Figure 1A). The targeting construct was designed
in a way that Cre-mediated recombination results in de-
letion of the promoter region containing essential regu-
latory NF-κB binding sites, the core promoter, and the
first two exons (Rupec et al., 1999). ES cell clones with
the desired loxP-flanked (floxed) ikba locus (+/flox)
were identified by Southern blot analysis (Figure 1B).
Germline-transmitting chimeras were obtained and
bred to 129Sv and C57BL/6 mice. Heterozygous mice
carrying a floxed ikba allele (ikba+/f) were intercrossed
to obtain homozygous ikbaf/f mice. These mice were
fertile and did not show any phenotypical or histologi-
cal abnormalities, suggesting that the two loxP sites
inserted into the ikba locus do not affect its function
(data not shown).
For germline deletion of the ikba gene, we crossed
ikbaf/f mice with Deleter-Cre mice (Schwenk et al.,
1995). Heterozygous ikbaf/ mice were intercrossed.
Offspring and implants were genotyped by PCR analy-
sis. The deletion of the loxP-flanked genomic region of
ikba resulted in complete loss of IκBα transcripts in all
tissues as shown by reverse transcriptase polymerase
chain reaction (RT-PCR) analysis (Figure 1C). Ikba/
mice were born with Mendelian frequencies. At the age
of 3 days and onward, ikba/ littermates of both inbred
129/Sv and mixed 129BL/6 background suffered from
severe growth retardation. At the age of 5 days, their
weight was about one-half that of wt pups, and they
consecutively died between days 6 and 7 after birth.
Organs of the IκBα-deficient mice formed normally.
Comparison with the ikba−/− mouse line did not reveal
phenotypic differences, indicating that the conditional
ikba allele is a null allele.
ikba/ Mice Develop a Myeloproliferative Disease
When ikba/ mice were analyzed in detail, a myelopro-
liferative syndrome becomes overt. Flow cytometric
analysis revealed a marked increase in Gr-1hi/Mac-1hi
granulocyte numbers in the liver of 3- and 5-day-old
/crease in Ter-119hi cells of the erythropoietic lineage
(Figure 2A). A moderate increase was already present
in 1-day-old livers. However, at embryonic day 12 (E12),
no significant difference was found in the proportion of
Gr-1hi/Mac-1hi granulocytes in the liver of ikba/ mice
compared to wt mice (ikba+/+) (Figure 2A). In order to
analyze whether the lack of IκBα influences NF-κB acti-
vation in Gr-1hi/Mac-1hi granulocytes, gel-retardation
assays were performed. Constitutive NF-κB binding ac-
tivity was found in Gr-1hi/Mac-1hi cells from ikba/
mice, providing evidence for the functional inactivation
of IκBα (Figure 2B). The NF-κB complex was composed
of p65/RelA and p50 subunits (see Figure S1 available
in the Supplemental Data online with this article). Histo-
logical examination of livers from 3-day-old and 5-day-
old ikba/ mice revealed a significant reduction of fetal
hematopoiesis in 5-day-old ikba/ mice (Figure 2C)
with an average of 4.5 colonies/1250 m2 in wt mice
and 2.5 colonies/1250 m2 in ikba/ mice. Histochem-
istry demonstrated an increase in cells positively
stained for the myeloid marker chloracetate esterase
(CAE; Figure 2D) with an average of 42/1250 m2 CAE-
positive cells in wt mice and 64/1250 m2 CAE-positive
cells in ikba/ mice.
A substantial increase of Gr-1hi/Mac-1hi granulocytes
and Ter-119hi erythropoietic cells was also observed in
the BM of ikba/ mice (Figure 3A). Next, the numbers
of myeloid progenitors in the BM were quantified ex vivo
by using colony-forming unit assays. Approximately a
2-fold increase in the number of BM-derived granulo-
cyte/erythroid/monocyte/macrophage colony-forming
units (CFU-GEMM) as well as GM-CFU, G-CFU, and
macrophage colony-forming unit (M-CFU) was ob-
served in BM cultures from 5-day-old ikba/ mice
compared to wt mice (Figure 3B). To determine whether
hypergranulopoiesis arises at the progenitor level, the
relative numbers of cycling myeloid cells in liver and
BM were quantified in vivo. In wt mice, the majority of
Gr-1hi/Mac-1hi cells were arrested in the G0/G1 phase
of the cell cycle with 9%–10% in the S and G2/M phase
(Figure 3C). In contrast, between 40% and 50% of Gr-
1hi/Mac-1hi cells from the ikba/ mice were in the S
and G2/M phase. Because only progenitor cells are mi-
totically active, these results suggest that ikba/ mice
have increased numbers of cycling progenitor cells.
The morphological analysis of BM of ikba/ mice
showed hypercellularity as compared to wt. Similar to
the liver, the cellular components were dominated by
the myeloid lineages and represented mostly granulo-
cytes with dysplastic features, characterized by pseudo-
Pelger-Huët formation (Figure 3C). Myelodysplasia could
also be detected in megakaryopoiesis by the presence
of micromegakaryocytes containing multiple small nu-
clei. Alterations in erythropoiesis were detectable by
Immunity
484Figure 4. Specific Disruption of Ikba in
Gr-1hi/Mac-1hi Granulocytes Remains with-
out Influence on Myelopoiesis
(A) Southern blot analysis of the thymus, as
an organ that does not express LysM, and
Gr-1hi/Mac-1hi granulocytes purified by flow
cytometry from the BM. Genotypes and po-
sitions of the expected 16.0 kb wt, 5.6 kb
flox, and 2.75 kb  bands are indicated.
(B) PCR analysis of genomic DNA from thy-
mus and Gr-1hi/Mac-1hi granulocytes puri-
fied by flow cytometry from the BM from
ikbamy/my mice. DNA isolated from the tail
of ikba/ mice serves as control.
(C) Western blot analysis with a IκBα-anti-
body of whole-cell extracts isolated from
thymus and Gr-1hi/Mac-1hi granulocytes of
ikbamy/my mice demonstrating the tissue-
specific loss of IκBα protein. Expression of
actin was used as loading control.
(D) EMSA of sorted primary Gr-1hi/Mac-1hi
granulocytes from 5-day-old ikba/ and
ikba+/+ mice with radiolabeled NF-κB con-
sensus oligonucleotide. The arrows indicate
the NF-κB-specific bands.
(E) Flow cytometric analysis of cells isolated
from BM and spleen (Sp) of 5-day-old and
12-week-old ikbamy/my and ikba+/+ mice.
(F) Flow cytometric analysis of cells isolated
from BM of 9-month-old IκBα-deficient fetal
liver cell chimera (ikbaFL/FL) and control fe-
tal liver cell chimera (ikbaFL+/FL+) gated on
Ly5.2. The data are representative for the
three mice of each genotype analyzed.Table 1. Peripheral Blood Counts in Fetal Liver Cell Chimeras
ikbaFL+/FL+ (n = 3) ikbaFL/FL (n = 3)
Leukocytes/l (× 103) 4.7 ± 0.7 5.1 ± 0.5
Erythrocytes/l (× 106) 8.8 ± 0.3 8.7 ± 0.3
Platelets/l (× 105) 996 ± 32 1072 ± 49
Neutrophil segments* 28.8 ± 3.4 24.8 ± 4.8
Neutrophil bands* 0.7 ± 0.2 0.8 ± 0.2
Lymphocytes* 66.0 ± 5.4 71.2 ± 4.4
Eosinophils* 2.9 ± 0.3 2.6 ± 0.4
Monocytes* 2.7 ± 0.3 2.2 ± 0.5
Results are the mean of the indicated numbers of 9- to 10-month-
old mice. An asterisk indicates the percentage of cells determined
by differential counts of 300 cells per blood smear.cleocytoplasmic ratio in the red cell precursor popula-
tion (Figure 3D). Consistent with these observations,
the peripheral blood of ikba/ mice showed elevated
white blood cell counts with dysplasia in the neutrophil
lineage including immature forms (Figure 3E). Together,
these results indicate that ubiquitous loss of IκBα re-
sults in hypergranulopoiesis progressing to a myelo-
dysplastic syndrome.
Deregulated Myelopoiesis in ikba/ Mice
Is Independent of IB Deficiency
in the Myeloid Lineage
To analyze whether the myeloproliferative disease is
cell autonomous, ikba was inactivated tissue specifi-
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485cally in cells of the myeloid lineage by crossbreeding
ikbaf/f mice with a Cre knockin line that expresses the
Cre recombinase under the control of the endogenous
mouse lysozymeM promoter (LysM-Cre) (Clausen et
al., 1999). Mice lacking ikba in the myeloid lineage
(ikbamy/my) were born with Mendelian frequencies. In
order to evaluate the efficiency of Cre-mediated dele-
tion of the floxed ikba gene, genomic DNA was ex-
tracted from Gr-1hi/Mac-1hi granulocytes. In Gr-1hi/
Mac-1hi granulocytes from ikbamy/+ mice, only an
ikba-specific band was detectable by Southern blot
and PCR analysis (Figures 4A and 4B). Western blot
analysis confirmed the absence of IκBα in Gr-1hi/Mac-
1hi granulocytes (Figure 4C). Expression of IκBα was
not disturbed in the thymus of ikbamy/my mice, and no
ikba-specific band was detectable by Southern blot
analysis of DNA extracted from thymus of ikbamy/+
mice (Figures 4A–4C). Absence of IκBα resulted in con-
stitutive activation of NF-κB in Gr-1hi/Mac-1hi granulo-
cytes isolated from ikbamy/my mice (Figure 4D). Sur-
prisingly, the constitutive activation of NF-κB had no
influence on the proportion of Gr-1hi/Mac-1hi cells in the
BM and spleen neither at day 5 nor at 12 weeks after
birth (Figure 4E). Histopathologic examination of liver
hematopoiesis in 5-day-old ikbamy/my mice was indis-
tinguishable from age-matched wt mice (data not
shown). Colony-forming assays performed with cells
isolated from BM did not show an increase in the num-
ber of CFUs, and no increase of granulocyte progeni-
tors was found in the BM by histological examination
(data not shown). Because Cre-mediated recombina-
tion of the ikba gene in ikbamy/my mice might occur
after the critical step in myeloid lineage differentiation,
fetal liver cell chimeras were generated (ikbaFL/FL) by
injection of IκBα-deficient fetal liver cells into irradiated
wt mice (Figures S2 and S3). Analysis of 6-month-old
fetal liver cell chimeras demonstrated no difference in
the proportion of Gr-1hi/Mac-1hi cells in the BM and
spleen (Figure 4F). Differential blood cell counts indi-
cated no dysmorphic features and no difference in neu-
trophilic granulocytes, eosinophilic granulocytes, ery-
throcytes, monocytes, and lymphocytes (Table 1).
Intriguingly, these results suggest that the development
of myeloid hyperplasia in ikba/ mice is not cell auton-
omous.
Altered Gene Expression in Myeloid Cells
from IB-Deficient Mice
Systemic analysis of transcription factors, growth
factor receptors, and NF-κB-regulated cell-survival
genes was performed to gain insight into the molecular
mechanisms underlying hypergranulopoiesis. Primary
Gr-1hi/Mac-1hi granulocytes isolated from BM and liver
derived from ikba+/+, ikba/, and ikbamy/my mice
were analyzed by RT-PCR in Figures 5A and 5B. Gr-1hi/
Mac-1hi cells isolated from BM and liver of ikba/ mice
expressed high levels of the transmembrane receptor
Notch1, a key regulator of cell-fate decisions during dif-
ferentiation. In contrast, Notch1 gene expression was
missing in Gr-1hi/Mac-1hi cells isolated from wt and
ikbamy/my mice that do not develop a myeloprolifera-
tive disorder. Activation of the Notch1 receptor on Gr-
1hi/Mac1hi granulocytes from ikba/ mice was indi-Figure 5. Altered Gene Expression in IκBα-Deficient Gr-1hi/Mac-1hi
Granulocytes
(A and B) Primary Gr-1hi/Mac-1hi granulocytes were purified by flow
cytometry from BM and liver of ikba/, ikbamy/my, and control
mice (n = 4). Cells were analyzed by RT-PCR for expression levels
of the indicated genes. Expression of tubulin was used as a loading
control for the RT-PCR.
(C) Quantitative real-time PCR analysis of notch1, hes1, and il-3r
expression in ikba/ Gr-1hi/Mac-1hi granulocytes. The gene ex-
pression levels were normalized by tubulin for each mRNA prepara-
tion, and the fold increase in Gr-1hi/Mac-1hi granulocytes from
ikba/ mice was calculated by comparison with the result obtained
from wt mice. Results are the mean ± SD of three mice.
(D) Percentage of apoptotic (Annexin-labeled) BM-derived, Gr-1-
positive granulocytes (upper right quadrant).cated by expression of the Notch1 target gene hes1
(Jarriault et al., 1995). Gr-1hi/Mac-1hi granulocytes from
ikba/, ikbamy/my, and wt mice displayed compara-
ble expression levels for the Ets family transcription
factor PU.1 that is important for the terminal differentia-
tion and function of neutrophils (Anderson et al., 1998),
as well as for myeloperoxidase. Higher expression
levels of the IL-3 receptor, relevant for the survival, pro-
liferation, and differentiation of myeloid progenitors, were
detected in Gr-1hi/Mac-1hi populations from ikba/
mice compared to ikbamy/my and wt mice. Expression
levels of the G-CSFα receptor (Figure 5A) and GM-
Immunity
486Figure 6. Persistent Expression of Jagged1 in IκBα-Deficient Hepatocytes
(A) Liver of E12, 3-day-old, and 5-day-old ikba/ and ikba+/+ mice immunostained with anti-Jagged1 antibody and isotype control.
(B) Primary hepatocytes isolated from 3-day-old ikba/ and ikba+/+ mice were analyzed by RT-PCR for jagged1 and g-csf expression.
Expression of tubulin was used as loading control.
(C) EMSA of primary Gr-1hi/Mac-1hi granulocytes from 5-day-old ikba/ and ikba+/+ mice with radiolabeled NF-κB consensus oligonucleotide.
The arrow indicates the NF-κB-specific band.
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487lodysplastic/myeloproliferative diseases (MDS/MPD)influences myeloid lineage differentiation, colony-form-
(D) Induction of jagged1 and notch1 on BM-derived stroma cells was measured by real-time detection RT-PCR with RNA samples prepared
from six different wt and ikba/ mice. Triplicate determination was made for each mRNA sample. The gene expression levels were normalized
by tubulin for each mRNA preparation, and the fold increase in ikba/ mice was calculated by comparison with the result obtained from wt
mice. Results are the mean ± SD of six mice.
(E) Colony-forming assays were performed with BM cells isolated from 5-day-old newborn ikba+/+ mice after culture for 1 week on ikba+/+ or
ikba/ hepatocytes with or without preincubation with Jagged1 antibody or control antibody (α-IκBα). As control for the specifity and
inhibitory function of the Jagged1 antibody, colony-forming assays were performed with BM cells isolated from 5-day-old ikba+/+ mice after
culture for 1 week on 3T3 cells and Jagged1-expressing 3T3 cells with or without preincubation with Jagged1 antibody. Results are the
mean ± SD of four analyzed mice per experimental group.
(F) Real-time RT-PCR of mRNA samples isolated from colonies after culture for 1 week on Jagged1-expressing 3T3 cells with or without
preincubation with Jagged1 antibody. The gene expression levels were normalized by tubulin for each mRNA preparation, and the increase
of mRNA obtained after culture with Jagged1 expressing 3T3 cells after preincubation with Jagged1 antibody was calculated by comparison
with the result obtained after culture with Jagged1-expressing 3T3 cells without preincubation with Jagged1 antibody. Results are the
mean ± SD of four mice per experimental group.CSFα receptor (data not shown) were comparable be-
tween Gr-1hi/Mac-1hi granulocytes from wt, ikba/, and
ikbamy/my mice. Quantitative real-time PCR revealed
Notch1 expression more than three times higher and
Hes-1 expression more than five times higher in ikba/
Gr-1hi/Mac-1hi granulocytes compared to wt neutro-
phils (Figure 5C). The fraction of apoptotic granulocytes
from 5-day-old ikba/ mice was determined by double
labeling using Gr-1 and AnnexinV antibodies. Ikba/
mice displayed no significant difference in the number
of Gr-1hi/AnnexinVhi apoptotic granulocytes when com-
pared to age-matched wt mice (Figure 5D). In accor-
dance, the antiapoptotic NF-κB target genes Bcl-2 and
Bcl-xL were not significantly differently expressed in
any of the analyzed cell populations (Figure 5A). These
results indicate that decreased apoptosis in ikba/ Gr-
1hi/Mac-1hi granulocytes is not responsible for the ele-
vated numbers of myeloid cells in the absence of IκBα.
Rather, Notch1-dependent signals appear to be re-
sponsible for the myeloproliferative disorder.
Jagged1 Expression Is Not Downregulated
in IB-Deficient Hepatocytes
Notch1 signaling can be activated through homo- or
heterotypic cell-cell interactions (Jennings et al., 1995;
Jennings et al., 1994). Hematopoietic stem cells and
progenitor cells form cell-cell contacts with murine fetal
liver stroma and BM stroma (Bentley, 1981; Varnum-Fin-
ney et al., 1998). Therefore, we examined Notch ligand
expression in tissues such as liver and BM that are rele-
vant for perinatal hematopoiesis. Immunohistochem-
istry revealed widespread Jagged1 expression in the
liver at E12 in wt and ikba/ mice (Figure 6A). Although
Jagged1 expression remained upregulated in ikba/
mice up to day 5 postpartum, its expression was re-
stricted predominantly to the endothelium surrounding
the central veins in 3-day-old wt mice. To investigate
Jagged1 expression on the transcriptional level, we an-
alyzed Jagged1 mRNA levels by RT-PCR from 5-day-
old ikba/ mice (Figure 6B). Clearly, Jagged1 expres-
sion in ikba/ hepatocytes and strong NF-κB binding
activity in ikba/ hepatocytes isolated from 5-day-old
mice were detectable (Figure 6C). The increased ex-
pression of Jagged1, paralleled by an upregulation of
Notch1, could also be demonstrated on BM-derived
stroma cells (Figure 6D). To determine whether the per-
sistent expression of Jagged1 on hepatocytes directlying assays were performed by cocultivating IκBα-defi-
cient and control hepatocytes with wt BM cells. A w4-
fold increase in the number of BM-derived CFUs was
observed when primary wt BM cells were cocultured
with IκBα-deficient hepatocytes compared to cocul-
tures with control hepatocytes (Figure 6E). Hypergranu-
lopoiesis was completely abolished after addition of a
Jagged1 antibody to the cultures. The specificity and
inhibitory function of the Jagged1 antibody, resulting in
a decrease of colony formation and downregulation of
Notch1 and Hes-1, could be also demonstrated in a
setting with Jagged1-expressing 3T3 cells (Figures 6E
and 6F). These results demonstrate that the Notch li-
gand Jagged1, transiently expressed in the liver during
embryogenesis, remains postnatally upregulated in
IκBα-deficient hepatocytes and leads to a deregulated
myelopoiesis.
Discussion
Gene-targeting experiments have demonstrated the
significance of individual NF-κB components and the
inhibitor IκBα for hematopoiesis in vivo. However,
the specific biological functions of the individual com-
ponents remain unclear. Our study demonstrates the
significance of IκBα for the regulation of the Jagged-
Notch signaling pathway for myelopoiesis. The ubiqui-
tous loss of IκBα expression in newborn ikba/ mice
results phenotypically in a myelodysplastic syndrome
(MDS) with a blast population of more than 20% in the
peripheral blood in all mice. In contrast to ikba/ mice,
in ikbamy/my mice with a specific deletion of IκBα in
granulocytes and macrophages as well as in IκBα-defi-
cient fetal liver cell chimeras (ikbaFL/FL), myelopoiesis
was not disturbed, and the number of granulocyte pro-
genitors was unaltered despite constitutive activation
of NF-κB in granulocytes. The absence of MDS in
ikbamy/my mice and ikbaFL/FL mice expressing NF-
κB constitutively in Gr-1hi/Mac-1hi granulocytes and
macrophages demonstrates that the absence of IκBα
and NF-κB activation in myelopoietic cells alone is not
sufficient for the induction of hypergranulopoiesis but
that deregulation of NF-κB in the nonhematopietic
compartment causes a myeloproliferative disorder. The
phenotypic hallmarks found in our mouse model re-
semble those found in chronic myelomonocytic leuke-
mia (CMML) in the group of unclassifiable human mye-
Immunity
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mcording to the WHO classification guidelines of tumors
of hematopoietic and lymphoid tissues (Jaffe et al., R
f2001). As up to now no specific cytogenetic or molecu-
lar genetic findings can be found in the group of unclas- c
isifiable MDS/MPD, our results suggest that mutation in
the ikba locus should be investigated. t
tA number of transgenic mouse models for human
MDS have been generated. However, MDS in these u
imodels is cell autonomous and results either from mu-
tations of genes found mutated in human MDS cells, a
oe.g., the receptor tyrosine kinase FLT3 (Kelly et al.,
2002) and the transcription factor C/EBPα (Gombart et c
Bal., 2002), or overexpression of the cell cycle molecule
cyclin A1 (Liao et al., 2001), a nucleoporin-homeobox l
sprotein NUP98-HOXA9 fusion protein (Kroon et al.,
2001), or the viral SV40 large T antigen (Inoue et al., h
c1994). Human MDS/MPD diseases, particularly CMML
and atypical CML, may have numerous cytogenetic ab- s
normalities, including +8, −7 del (7q), and structural ab-
normalities of 12p as well as abnormal fusion genes like i
cTEL/PDGFbR, which, however, might have been ac-
quired later during the disease. J
tThe function of BM stroma for the development of
MDS is still under discussion (Deeg et al., 2002). Al- c
tthough Aizawa et al. (1999) report on the development
of MDS with refractory anemia on a BM stroma that 2
ais defective to support hematopoietic proliferation and
differentiation in vitro, Deeg et al., (2000) have found t
sthat MDS marrow has no inhibitory effect on hemato-
poietic clonality. Instead, higher CFUs were obtained c
2from both normal and MDS marrow-derived hemato-
poietic precursors when propagated on irradiated stro- u
wmal layers from MDS marrow compared to stromal lay-
ers from normal marrow. A recent report describes an m
Nincreased production of TNF by MDS BM stroma cells
(Flores-Figueroa et al., 2002). However, we could not c
tobserve any difference in the hematopoietic phenotype
between ikba/ mice and the offspring from cross- c
vbreedings of ikba/ mice with TNFIII mice deficient for
TNF, LT-α, and LT-β (Kuprash et al., 2002) (data not d
wshown).
The Notch1 ligand Jagged1 is strongly expressed in o
the liver of wt and ikba/ mice at embryonic day 12,
but not in Gr-1hi/Mac-1hi granulocytes (data not shown). s
mAs hematopoiesis in the mouse originating in the yolk
sac occurs in the liver at E12, a role for Jagged1 in the a
kregulation of hematopoiesis in the fetal liver is prob-
able. The coincidence of persistent Jagged1 expres- M
ision and increased myelopoiesis in our mouse model
emphasizes a myelopoiesis-inducing function of Jag- G
tged1 in nonhematopoietic cells. Interestingly, the in-
crease in Ter-119hi cells of the erythropoietic lineage t
pverifies the in vivo relevance of Jagged1 for erythropoi-
esis, which has to be further investigated in the future. p
oAs IκBα is a physiological inhibitor of NF-κB, and NF-
κB is found constitutively expressed in ikba/ hepato- o
dcytes, it can be suggested that Jagged1 expression in
the fetal liver is regulated by NF-κB. The induction of o
gJagged1 transcripts by the NF-κB subunits c-Rel and
RelA has been demonstrated previously in vitro (Bash m
et al., 1999). However, a direct regulation of Jagged1
expression by NF-κB still has to be shown. i
iNotch proteins regulate cell-fate decisions and differ-ntiation processes during fetal and postnatal develop-
ent (for review see Milner and Bigas [1999] and
adtke et al. [2004]). However, conclusive in vivo data
or Notch function in myelopoiesis are lacking. Further
haracterization of Gr-1hi/Mac-1hi granulocytes from
kba/ mice revealed elevated levels of Notch1 recep-
or expression. Our finding of Notch1 being constitu-
ively upregulated and activated in Gr-1hi/Mac-1hi gran-
locytes in context with a hypergranulopoiesis found
n ikba/ mice supports the concept of Notch1 as an
ctivator of myelopoiesis. The increase in the number
f ikba/ BM-derived CFU-GEMMs as well as the in-
rease of Gr-1hi/Mac-1hi granulocytes in the liver and
M of ikba/ mice indicate that Notch1 controls mye-
opoiesis at an early progenitor level. The overexpres-
ion of the Notch1 basic helix-loop-helix target gene
es1 proves the activity of Notch1 and promotes the
oncept of Hes1 as a factor relevant for lineage deci-
ion (Kawamata et al., 2002; Tan-Pertel et al., 2000).
The contradictory findings in the different ex vivo and
n vitro studies may be due to the varying coculture
onditions, growth factors supplements, and Notch1/
agged1-expressing cell lines and expression vectors
hat were used. In addition to the growth-promoting
apacity of primitive hematopoietic precursor cells
hrough Jagged1 (Jones et al., 1998; Karanu et al.,
000; Varnum-Finney et al., 1998), it has been shown in
n in vivo model that lethally irradiated mice reconstitu-
ed with constitutive Notch1-signaling hematopoietic
tem cells generated progeny with myeloid or lymphoid
haracteristics (Stier et al., 2002; Varnum-Finney et al.,
000). In our model, Notch1 is expressed genetically
nmodified, and no transfection of cells or cell lines
ith expression constructs was employed. Thus, our
ouse model demonstrates the physiologic function of
otch1 in vivo best and shows at the same time that
onstitutive overexpression of intact Notch1 results in
he development of myelodysplasia progressing to se-
ondary acute myeloid leukemia. Nevertheless, it is
ery likely that additional stromal ligands and cytokines
irectly or indirectly regulated by the NF-κB-IκBα path-
ay are involved in the development of the phenotype
f the ikba/ mice.
An increased expression of Notch1 has also been
hown in cell lines isolated from patients with acute
yeloid leukemia (Tohda and Nara, 2001). This was par-
lleled by an upregulation of Jagged1 expression in leu-
emic cells. As Jagged1 was not expressed in Gr-1hi/
ac-1hi granulocytes isolated from ikba/ mice and
kbaFL/FL mice (data not shown), its expression in
r-1hi/Mac-1hi cells does not seem to be essential for
he development of MDS in our mouse model, pointing
o the relevance of a tight regulation of Jagged1 ex-
ression on nonhematopoietic cells. Constitutive ex-
ression of Notch1 has been associated with the devel-
pment of T cell leukemias. The reason why we cannot
bserve the development of a T cell neoplasia may be
ue to the short life span of the ikba/ mice. On the
ther hand, a Notch ligand, Delta-1, different from Jag-
ed1 has been shown to be crucial for T cell develop-
ent (Schmitt and Zúniga-Pflu¨cker, 2002).
The increased expression of the IL-3 receptor in
kba/ Gr-1hi/Mac-1hi granulocytes may be due to an
ncrease in the number of progenitor cells. In ikbamy/my
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489mice with a specific deletion of IκBα in granulocytes
and macrophages as well as in ikbaFL/FL mice (data
not shown), no increased expression of the IL-3 recep-
tor was found, suggesting that il-3r transcription can
also be directly or indirectly induced by Jagged1 ex-
pression in hepatocytes.
The floxed ikba mice may provide a unique tool to
study the function of stromal cells for fetal myelo-
poiesis and the development of MDS. In addition, the
ikba/ mice may be useful for the identification of
genes contributing to both the myeloproliferative dis-
ease and the progression to blast crisis and ultimately
to design effective therapies to interfere with these mo-
lecular events.
Experimental Procedures
Targeting Vector
A human ikba cDNA (Haskill et al., 1991) was used to isolate clones
from a 129/SvJ mouse liver genomic library (Stratagene). Murine
ikba genomic clones were restriction mapped by using the human
ikba sequence. The structure of the ikba locus was described pre-
viously (Rupec et al., 1999). The ikba targeting construct was gen-
erated starting from two consecutive genomic subclones covering
the entire ikba locus: 5#-Not carried a 8.6 kb NotI fragment covering
the promoter region and exon I, and clone 3#-Not harbored a 2.2
kb NotI fragment covering exons II–VI. The neomycin restriction
gene (neor ) cassette flanked by two loxP sites was introduced into
the second intron. An oligonucleotide containing an additional loxP
site and KpnI site was introduced at position +1182 of ikba (relative
to the start of transcription). A herpes simplex virus (HSV)-tk cas-
sette was introduced at the NotI site of 5#-Not.
Targeting and Generation of Conditional Ikba Knockout Mice
The targeting construct was linearized with ClaI on the short arm
homology site and transfected into E14.1 ES cells by electropora-
tion. The transfection, culture, and selection of ES cells were per-
formed as described previously (Neubauer et al., 1998; Pfeffer et
al., 1993). The correct recombination event was verified by blotting
ES cell DNA after digestion with KpnI and hybridization with the 3#
flanking probe. Chimeric mice were generated from ikba +/flox ES
cells by injection of C57BL/6 blastocysts. Chimeric mice obtained
from ikba +/flox ES cell lines were crossed with C57BL/6 wt mice.
Germ line transmission of the targeted allele was identified by
Southern blot analysis. Mice were genotyped by PCR (sequence
available upon request); the expected sizes of the PCR products
are 363 bp for the floxed allele and 275 bp for the wt allele.
Adoptive Transfer of Fetal Liver Cells
Ikba+/ mice were backcrossed for more than seven generations
with C57BL/6-Ly5.2 mice. Fetal livers were harvested from day 12
embryos, and single-cell suspensions were prepared. To determine
genotypes, fetal tissue was washed with 1 ml of phosphate-buf-
fered saline resuspended in 1 × PCR buffer containing 10 µg pro-
teinase K/ml, 0.045% NP40, and 0.045% Tween 20. Cell suspension
was incubated at 55°C for 30 min. The protease was inactivated for
10 min at 100°C, and 2 µl of the lysate was used to genotype by
standard PCR reaction. Expected sizes for the PCR products are
220 bp for the recombined allele and 180 bp for the wt allele. Within
6 hr, 8 × 105 to 1 × 106 viable cells were injected into the tail veins
of 8- to 10-week-old µMT-Ly5.1 mice that had received 800 rad of
γ irradiation. Mice were maintained in autoclaved cages. Fetuses
of the desired phenotype were derived from ikba+/FL matings.
Detection of Cre-Mediated Recombination
To obtain total knockout mice (ikba/), ikbaf/f mice were crossed to
the mouse line deleting the floxed allele in the germline (DeleterCre)
(Schwenk et al., 1995). The recombined allele was detected by PCR
(sequence available upon request); the expected size of the recom-
bined allele was 526 bp. For site-specific recombination in neutro-phils, ikbaf/f mice were crossed with LysMCre mice (Clausen et
al., 1999).
Clonality Assay for Hematopoetic Progenitors
The femur was removed from the sacrificed animal and flushed
several times with ice-cold PBS. The BM was minced through a
metal grid, and cells were washed several times in Hanks-buffered
salt solution (HBSS) before separation by a Ficoll gradient (d =
1.077). The mononucleated cells were washed and 50,000 cells
were grown in 2 ml of MethoCult GF M3434 (StemCell Technologies
Inc.). For the coculture experiments, 2 × 106 primary ikba+/+ BM
cells per well were plated either on 2 × 106 ikba/, 2 × 106 ikba+/+
hepatocytes, 3T3 cells, or Jagged1-expressing 3T3 cells. After 1
week of culture in 3 ml Dulbecco’s modified Eagle’s medium
(DMEM) (GIBCO/BRL) supplemented with 10% fetal calf serum
(FCS) (Biochrom KG), L-glutamine (Invitrogen), gentamycin (Invitro-
gen), 2-mercaptoethanol (Sigma), IL-7 (Sigma), IL-3 (Sigma), GM-
CSF (Sigma), and SCF (Sigma) culture dishes, cells were counted
and passaged into methylcellulose cultures. The number of colo-
nies (>50 cells/clone) were counted at different time points and de-
scribed according to their morphology and size. For the inhibitory
experiments, 0.5 mg/ml Jagged1 antibody (Sigma) or control anti-
body (α-IκBα, Santa-Cruz Inc.) were added to the culture medium.
Histology of Liver, BM, and Peripheral Blood
The contralateral femur of the sacrificed animals was removed and
fixed in 4% formaldehyde before decalcification in ethylenediami-
netetraacedic acid (EDTA) for 24 hr. Afterward, the entire femur was
imbedded in paraffin and 0.5 µm serial sections were stained with
Wright-Giemsa, Period-Schiff Acid solution (PAS), hematoxylin-
eosin (HE), Elastica-van-Gieson, and Prussian Blue. Peripheral
blood smears were stained with Wright-Giemsa for further evalua-
tion of cytology and cell numbers. Liver sections were fixed in 4%
formaldehyde/PBS, paraffin embedded, sectioned, and stained
with HE. CAE (Sigma) staining was performed according to the
manufacturer’s instructions. For determination of the number of
hematopoietic colonies, an area of solid hepatocyte tissue was
chosen and photographed under 200-fold magnification. In the
center of the photograph, eight areas of 1250 m2 were randomly
chosen, measured with Zeiss Axio Vision 4.1 software, and the
number of colonies counted. Comparative analysis was done by
setting the area numbers in correlation. CAE-positive cells were
counted in the same way under 400-fold magnification.
Immunohistochemistry
Livers of ikba/ and ikba+/+ mice were snap frozen in 2-methylbu-
tane (Merck) prechilled in liquid nitrogen and embedded in OCT
Tissue Tec Media (Miles Inc.). 5 M sections were cut by using a
Cryotom (Leica). Frozen sections were fixed in 4% PBS and rinsed
once in H20 and twice in Tris buffer. To block unspecific binding,
the ABC-system block and secondly the Avidin-Biotin Block
(DAKO) were applied. Slides were rinsed twice in Tris buffer and
incubated with anti-Jagged1 antibody (R&D Systems) (1:10,000)
followed by two washes in Tris buffer. Biotin (Vector-Systems) was
added followed by two washes in Tris buffer and addition of Strep-
tavidin (Vector-Systems). AEC (Sigma) was applied after two
washes in Tris buffer until the desired color intensity developed.
After washing in H2O, sections were counterstained in hematoxylin
(Vector), washed in H2O, and coversliped with Aquatex (Merck).
Electrophoretic Mobility Shift Assay
Electrophoretic mobility assays and supershift assays were per-
formed as described previously (Rupec and Baeuerle, 1995). The
NF-κB ELISA was performed according to the instructions of the
manufacturer (Active Motif).
Flow Cytometry and Cell Sorting
Cell were resuspended at 1 × 106 per 100 l of PBS containing 1%
FCS, pretreated with Fc block (anti-CD16/anti-CD32, Pharmingen),
and stained for 30 min at 4°C with the indicated mouse antibodies.
Viable cells, as determined by forward and side scatter profiles
obtained with a FACSCalibur (Becton Dickinson), were analyzed
with CellQuest software or sorted with a MoFlo Sorter (Cytoma-
Immunity
490tion). Apoptosis was analyzed with an Annexin-V/7AAD Kit (Roche) (
according to the instructions of the manufacturer. For DNA content p
analysis, Gr-1-stained cells were isolated from the BM of 5-day-old p
ikba/ and wt mice and fixed in 70% methanol overnight, washed 2
twice with PBS, and resuspended in 425 l PBS, and 50 l RNase A
(1 mg/ml) (Sigma) was added. After incubation at 37°C for 20 min, c
25 l propidium iodide (1 mg/ml) was added before FACS analysis. e
ART-PCR and Western Blot Analysis
(Total RNA was isolated by using Trizol reagent (GIBCO/BRL). For
oall RT-PCR and real-time quantitative RT-PCR analyses, 1 g total
BRNA was digested with DNase I (Sigma) to remove DNA contamina-
ation and reverse transcribed with SuperScript II according to the
manufacturer’s instructions (GIBCO/BRL). PCR amplifications were p
performed with standard conditions. Each PCR product was elec- r
trophoresed on agarose gels in 1XTAE, stained with ethidium bro- B
mide, and photographed. Each gene was analyzed by using spe- s
cific primer pairs (sequence available upon request). Protein l
extracts and Western blot analyses were performed according to
Bstandard procedures with 20 g of whole-cell extracts. The IκBα
santibody was obtained from Santa-Cruz and the actin antibody
Hfrom Sigma.
B
iCell Culture
Minced liver tissues from 3-day-old ikba/ and wt mice were dis- M
sociated with enzyme-based dissociation buffer (liver digest me- C
dium) followed by hemolysis with hypotonic buffer. Dissociated N
cells were suspended in culture media composed of DMEM f
(GIBCO/BRL) supplemented with 10% FCS (Biochrom KG), 2 mM 8
L-glutamine (GIBCO/BRL), 1 × nonessential amino acid solution
C(GIBCO/BRL), 1 × insulin-transferrin-selenium X (ITS) (GIBCO/BRL),
I50 g/ml gentamycin (GIBCO/BRL), and 0.1 mM 2-mercapto-
cethanol (GIBCO/BRL) and plated onto 0.1% gelatine-coated tissue
culture dishes. Several hours later, contaminating hematopoietic D
cells and cell debris were removed by extensive washing with tis- S
sue culture medium. Jagged1-transfected 3T3 cells and control p
3T3 cells were cultured in DMEM (GIBCO/BRL) supplemented with d
10% FCS (Biochrom KG), 2 mM L-glutamine (GIBCO/BRL), 1 × D
nonessential amino acid solution (GIBCO/BRL), and 0.1 mM 2-mer- S
captoethanol (GIBCO/BRL). p
Primary mouse stromal cells were obtained mincing the femurs f
of sacrificed mice through a 100 m nylon cell strainer. Cells were
6
initially cultured in Jagged1-transfected 3T3 cells and control 3T3
Fcells in DMEM (GIBCO/BRL) supplemented with 10% FCS (Bio-
achrom KG), 2 mM L-glutamine (GIBCO/BRL), 1 × nonessential
hamino acid solution (GIBCO/BRL), 0.1 mM 2-mercaptoethanol
d(GIBCO/BRL), and 50 g/ml gentamycin (GIBCO/BRL) and then
transferred to methylcellulose. F
I
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